跳至主要内容
临床试验/NL-OMON52352
NL-OMON52352招募中不适用

Differences in antihypertensive drug levels in patients with hypertension: old vs young - 2 - DECISION-2

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Use of oral perindopril 2, 4 or 8 mg a day or losartan 25, 50 or 100 mg a day
  • or in case of healthy controls willingness to use perindopril 4 mg or losartan
  • 50 mg for five days
  • - Age between 18-50 years or > 70 years
  • - Providing informed consent after reading the patient information
  • - Stopping is in accordance with the treating physician

排除标准

  • Not providing informed consent or not capable of giving informed consent, •
  • End-stage renal disease (eGFR<15 ml/min) • Use of other antihypertensive drugs
  • prescribed that are of influence on the RAAS system incuding diuretics, beta
  • blockers and other RAAS-inhibitors.

研究者

相似试验